Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 5/20 | 0.47 |
| ▸ | FGF1 | P05230 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | PYGB | P11216 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31653946 | 0.89 | MAPK1 (0.43) | LGALS8GAAMAPK1L3MBTL1LGALS3 | |
| SCHEMBL13758175 | 0.86 | LGALS8 (0.47) | LGALS8GAALGALS3LGALS4 | |
| SCHEMBL19255530 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL22098622 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL7147710 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL23705114 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL7153250 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL7151279 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL7147713 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT | |
| SCHEMBL10260243 | 0.85 | LGALS8 (0.51) | LGALS8FGF1GAAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3345490-A1 | BEVERAGE COMPRISING REBAUDIOSIDE X | The Coca-Cola Company (US) | 2018-07-11 | — | — | EP | disclosed |